期刊
NATURE
卷 488, 期 7411, 页码 384-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature11259
关键词
-
资金
- American Cancer Society fellowship [PF-09-137-01-TBE]
- Li Foundation Fellowship
- California Institute for Regenerative Medicine fellowship [TG2-01153]
- National Institutes of Health [PN2EY016546, RO1GM055040, RO1GM062583, P50GM081879]
- NSF Synthetic Biology and Engineering Research Center
- Packard Foundation
- Howard Hughes Medical Institute
Bacterial pathogens have evolved specific effector proteins that, by interfacing with host kinase signalling pathways, provide a mechanism to evade immune responses during infection(1,2). Although these effectors contribute to pathogen virulence, we realized that they might also serve as valuable synthetic biology reagents for engineering cellular behaviour. Here we exploit two effector proteins, the Shigella flexneri OspF protein(3) and Yersinia pestis YopH protein(4), to rewire kinase-mediated responses systematically both in yeast and mammalian immune cells. Bacterial effector proteins can be directed to inhibit specific mitogen-activated protein kinase pathways selectively in yeast by artificially targeting them to pathway-specific complexes. Moreover, we show that unique properties of the effectors generate new pathway behaviours: OspF, which irreversibly inactivates mitogen-activated protein kinases(4), was used to construct a synthetic feedback circuit that shows novel frequency-dependent input filtering. Finally, we show that effectors can be used in T cells, either as feedback modulators to tune the T-cell response amplitude precisely, or as an inducible pause switch that can temporarily disable T-cell activation. These studies demonstrate how pathogens could provide a rich toolkit of parts to engineer cells for therapeutic or biotechnological applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据